CA3106151A1 — Breath measurement device
Assigned to Individual · Expires 2020-01-16 · 6y expired
What this patent protects
An inhalation interface may monitor and analyze flow rate in an inhalation device. The inhalation interface may be calibrated for a user. The inhalation interface may send usage data to a user for review. In some embodiments the inhalation interface may send usage data to a physi…
USPTO Abstract
An inhalation interface may monitor and analyze flow rate in an inhalation device. The inhalation interface may be calibrated for a user. The inhalation interface may send usage data to a user for review. In some embodiments the inhalation interface may send usage data to a physician and provide active feedback to a patient. The active feedback may indicate when the flow rate during an inhalation is within a target threshold.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.